368 related articles for article (PubMed ID: 35844369)
1. Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update.
Selvamani S; Mehta V; Ali El Enshasy H; Thevarajoo S; El Adawi H; Zeini I; Pham K; Varzakas T; Abomoelak B
Saudi J Biol Sci; 2022 May; 29(5):3546-3567. PubMed ID: 35844369
[TBL] [Abstract][Full Text] [Related]
2. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
3. Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
Healey GR; Celiberto LS; Lee SM; Jacobson K
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092150
[TBL] [Abstract][Full Text] [Related]
4. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease.
Pandey H; Jain D; Tang DWT; Wong SH; Lal D
Intest Res; 2024 Jan; 22(1):15-43. PubMed ID: 37935653
[TBL] [Abstract][Full Text] [Related]
6. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
9. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD.
Martyniak A; Medyńska-Przęczek A; Wędrychowicz A; Skoczeń S; Tomasik PJ
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944546
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
Wasilewski A; Zielińska M; Storr M; Fichna J
Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
[TBL] [Abstract][Full Text] [Related]
11. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
13. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
[TBL] [Abstract][Full Text] [Related]
14. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.
Khan I; Ullah N; Zha L; Bai Y; Khan A; Zhao T; Che T; Zhang C
Pathogens; 2019 Aug; 8(3):. PubMed ID: 31412603
[TBL] [Abstract][Full Text] [Related]
15. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics, probiotics and prebiotics in IBD.
Bernstein CN
Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
[TBL] [Abstract][Full Text] [Related]
18. Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease.
Kavita ; Om H; Chand U; Kushawaha PK
Microbiol Res; 2024 Feb; 279():127550. PubMed ID: 38016379
[TBL] [Abstract][Full Text] [Related]
19. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease.
Zuo T; Ng SC
Front Microbiol; 2018; 9():2247. PubMed ID: 30319571
[TBL] [Abstract][Full Text] [Related]
20. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.
Scaldaferri F; Gerardi V; Lopetuso LR; Del Zompo F; Mangiola F; Boškoski I; Bruno G; Petito V; Laterza L; Cammarota G; Gaetani E; Sgambato A; Gasbarrini A
Biomed Res Int; 2013; 2013():435268. PubMed ID: 23991417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
